OncoMed Pharmaceuticals | Evaluate

September 21, 2017

Taiho shows Arcus trying to repeat the Flexus trick

Snippet roundup: Tesaro's Parp pricing stumble and Asco sneak peek

April 11, 2017

Double trouble sinks Oncomed as investors look to earlier assets

January 24, 2017

Asco-GI – Pancreatic cancer field awaits sparse data

September 29, 2016

Esmo preview – Novel checkpoints add to the Parp showdown

August 26, 2016

Esmo preview – A Merck versus Bristol showdown

April 29, 2016

AbbVie caps week of cancer deals with huge Stemcentrx takeout

February 05, 2016

Pancreatic cancer 2016: this time it’s (getting) personal

February 03, 2016

No safe haven as January crash wipes $644bn off biopharma

January 26, 2016

OncoMed digs itself out from under Alpine avalanche

September 17, 2014

Esmo preview – Immuno-oncology and beyond

Load More